LaylaAbushamatMDMPH
Endocrinology • Houston, TXDiabetes, Lipid Metabolism, Obesity
Assistant Professor
Dr. Abushamat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7200 Cambridge St
Houston, TX 77030Phone+1 713-798-1000Fax+1 713-798-2578
Education & Training
University of ColoradoFellowship, Endocrinology, Diabetes, and Metabolism, 2018 - 2020
University of FloridaResidency, Internal Medicine, 2015 - 2018
Tulane University School of MedicineClass of 2015
Certifications & Licensure
TX State Medical License 2021 - 2025
CO State Medical License 2018 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Trends in Cardiovascular Disease-Related Mortality in Texas.Muhammad Shariq Usman, Adeena Jamil, Zainali Chunawala, Mahboob Alam, Vijay Nambi
Texas Heart Institute Journal. 2024-12-19 - Comparing Cardiovascular Risk Classification of U.S. Adults According to Pooled Cohort Equations and PREVENT Equations: Cross-Sectional Analysis of the National Health...Abdul Mannan Khan Minhas, Salim S Virani, Erin D Michos, Vijay Nambi, Roger S Blumenthal
Annals of Internal Medicine. 2024-10-01 - Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity?Jennifer M Kaplan, Adnin Zaman, Layla A Abushamat
Current Cardiology Reports. 2024-09-01
Press Mentions
Evolocumab Reduces MACE in Patients with and Without Multivessel CAD: FOURIERFebruary 9th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
